Brief: Axsome Therapeutics Q2 Net Income USD -79.345 Million
05/08/2024 12:00
Aug 05 (Reuters) - Axsome Therapeutics Q2 pretax profit USD -79.345 million. * Q2 operating income USD -78.046 million * Q2 basic EPS USD -1.67 * Q2 operating expenses USD 165.212 million
Recent news on Axsome Therapeutics
See all newsUS RESEARCH ROUNDUP-Bright Minds Biosciences, Marvell Technology, Oracle Corporation
Axsome Therapeutics Q3 revenue rises on Auvelity and Sunosi
US RESEARCH ROUNDUP-Apple, Kaiser Aluminum, Reliance
Axsome Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Axsome Therapeutics Q2 revenue rises on AUVELITY growth